| Company Name: |
BOC Sciences
|
| Tel: |
1-631-485-4226; 16314854226 |
| Email: |
info@bocsci.com |
| Products Intro: |
Product Name:Abrilumab
CAS:1342290-43-0
Remarks:Reach out to us for more information about custom solutions.
|
| Company Name: |
Shanghai YuanYe Biotechnology Co., Ltd.
|
| Tel: |
021-61312847; 18021002903 |
| Email: |
3008007409@qq.com |
| Products Intro: |
Product Name:Abrilumab (anti-Integrin α4β7)
CAS:1342290-43-0
Purity:Low Endotoxin, Azide Free, Validated, Carrier Free, Recombin Package:100μg Remarks:K14059
|
| Company Name: |
ShangHai Biochempartner Co.,Ltd
|
| Tel: |
177-54423994 17754423994 |
| Email: |
2853530910@QQ.com |
| Products Intro: |
Product Name:Abrilumab
CAS:1342290-43-0
Purity:95% Package:100ug;500ug;1mg
|
| Company Name: |
Guangzhou Hongyuan Chemical Co.,Ltd
|
| Tel: |
15817493340 |
| Email: |
981810490@qq.com |
| Products Intro: |
Product Name:Abrilumab
CAS:1342290-43-0
Purity:95% Package:1mg;1g;100g
|
Abrilumab manufacturers
- Abrilumab
-
- $247.00 / 1mg
-
2026-01-05
- CAS:1342290-43-0
- Min. Order:
- Purity: 98.5% (SDS-PAGE); 99% (SEC-HPLC)
- Supply Ability: 10g
|
| | Abrilumab Basic information |
| Product Name: | Abrilumab | | Synonyms: | Abrilumab;Research Grade Abrilumab(DHC98804);Research Grade Abrilumab;Abrilumab (anti-Integrin α4β7) | | CAS: | 1342290-43-0 | | MF: | | | MW: | 0 | | EINECS: | | | Product Categories: | | | Mol File: | Mol File | ![Abrilumab Structure]() |
| | Abrilumab Chemical Properties |
| form | Liquid | | color | Colorless to light yellow |
| | Abrilumab Usage And Synthesis |
| Uses | Abrilumab is a fully human monoclonal antibody directed against α4β7. Abrilumab selectively binds the α4β7 integrin heterodimer. Abrilumab can be used for the research of inflammatory bowel disease (IBD)[1]. | | References | [1] Iris Dotan, et al. The role of integrins in the pathogenesis of inflammatory bowel disease: Approved and investigational anti-integrin therapies. Med Res Rev DOI:10.1002/med.21601
[2] Christopher A Lamb, et al. Gut-Selective Integrin-Targeted Therapies for Inflammatory Bowel Disease. J Crohns Colitis. 2018 Aug 22;12(suppl_2):S653-S668. DOI:10.1093/ecco-jcc/jjy060 |
| | Abrilumab Preparation Products And Raw materials |
|